VIDEO: Calabrese discusses ‘breakthroughs in neuroimmunology’

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a recent cover story examining how the practice of rheumatology has changed across generations.
“We have four outstanding rheumatologists ranging from the senior stateman Philip Mease, MD, who deserves no introduction whatsoever, because everyone knows him, to a bunch of young rheumatologists at the other end, including my daughter Cassandra [Calabrese, DO],” he said. “It’s really an interesting dialogue about changes in science, changes in the medical

More discolored sputum linked to higher bronchiectasis activity

PHOENIX — Among patients with bronchiectasis, those with purulent vs. mucoid or mucopurulent sputum had higher measures of neutrophil serine protease activity, according to results presented at the CHEST Annual Meeting.
“As sputum gets more green, you’ve got marked increases in neutrophilic inflammation. Validating that sputum color, as reported by the patient, is really quite an accurate way of measuring who is more neutrophilic and who is less neutrophilic,” James D. Chalmers, MBChB, PhD, of the Radcliffe Department of Medicine at the University of Oxford, said during his presentation.
In a

Xolair biosimilar Omlyclo commercially available in US

The Xolair/omalizumab biosimilar Omlyclo, FDA approved for the treatment of four allergic and inflammatory conditions, is commercially available in the U.S., according to a press release.
“Biologics have changed what is possible for patients with allergic and inflammatory diseases, but they are also some of the most expensive medicines in the U.S. health system,” Juby Jacob-Nara, MD, DHSc, MPH, MBA, senior vice president and chief medical officer at Celltrion USA, told Healio. “That cost reaches patients through prior authorizations, step therapy and high out-of-pocket costs, and for some it